How Accelerate Diagnostics Inc (AXDX) Stock converts water flow into cash flow
Craig Hallum raised the price target for the Accelerate Diagnostics Inc (NASDAQ:AXDX) stock from “a Buy” to “a Hold”. The rating was released on March 09, 2022, according to finviz. The research report from Craig Hallum has upgraded the stock from Hold to Buy, with a price target set at $20. The stock was downgraded […]
